Farnesoid X receptor (FXR): Structures and ligands (vol 19, pg 2148, 2021)

被引：0
|
作者：
Jiang, Longying [1 ,2 ]
Zhang, Huajun [2 ]
Xiao, Desheng [1 ]
Wei, Hudie [1 ,2 ]
Chen, Yongheng [1 ,2 ]
机构：
[1] Cent South Univ, Xiangya Hosp, Natl Clin Res Ctr Geriatr Disorders, Dept Pathol,NHC Key Lab Canc Prote,Lab Struct Biol, Changsha 410008, Hunan, Peoples R China
[2] Cent South Univ, Xiangya Hosp, Natl Clin Res Ctr Geriatr Disorders, Dept Oncol,NHC Key Lab Canc Prote,Lab Struct Biol, Changsha 410008, Hunan, Peoples R China
来源：
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL | 2022年 / 20卷
关键词：
D O I：
10.1016/j.csbj.2022.02.0292001-0370
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：1227 / 1228
页数：2
相关论文
共 50 条
  • [21] Role of Farnesoid X Receptor (FXR) in control of plasma lipid levels
    Claudel, T
    Elzinga, BM
    Bloks, V
    Staels, B
    Voshol, PJ
    Kuipers, F
    ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (01) : 95 - 96
  • [22] Regulation of the farnesoid X receptor (FXR) by bile acid flux in rabbits
    Xu, GR
    Pan, LX
    Li, H
    Forman, BM
    Erickson, SK
    Shefer, S
    Bollineni, J
    Batta, AK
    Christie, J
    Wang, TH
    Michel, J
    Yang, S
    Tsai, R
    Lai, L
    Shimada, K
    Tint, GS
    Salen, G
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (52) : 50491 - 50496
  • [23] Farnesoid-X Receptor (FXR) as a Promising Pharmaceutical Target in Atherosclerosis
    Moris, Demetrios
    Giaginis, Constantinos
    Tsourouflis, Gerasimos
    Theocharis, Stamatios
    CURRENT MEDICINAL CHEMISTRY, 2017, 24 (11) : 1147 - 1157
  • [24] Characterizing ligands for farnesoid X receptor - available in vitro test systems for farnesoid X receptor modulator development
    Merk, Daniel
    Steinhilber, Dieter
    Schubert-Zsilavecz, Manfred
    EXPERT OPINION ON DRUG DISCOVERY, 2014, 9 (01) : 27 - 37
  • [25] Bile Diversion Improves Metabolic Phenotype Dependent on Farnesoid X Receptor (FXR)
    Pierre, Joseph F.
    Li, Yuxin
    Gomes, Charles K.
    Rao, Prahlad
    Chang, Eugene B.
    Yin, Deng Ping
    OBESITY, 2019, 27 (05) : 803 - 812
  • [26] Targeting Farnesoid X receptor (FXR) for developing novel therapeutics against cancer
    Sosmitha Girisa
    Sahu Henamayee
    Dey Parama
    Varsha Rana
    Uma Dutta
    Ajaikumar B. Kunnumakkara
    Molecular Biomedicine, 2
  • [27] Targeting Farnesoid X receptor (FXR) for developing novel therapeutics against cancer
    Girisa, Sosmitha
    Henamayee, Sahu
    Parama, Dey
    Rana, Varsha
    Dutta, Uma
    Kunnumakkara, Ajaikumar B.
    MOLECULAR BIOMEDICINE, 2021, 2 (01):
  • [28] On the relationship of anthranilic derivatives structure and the FXR (Farnesoid X receptor) agonist activity
    Kronenberger, Thales
    Windshugel, Bjorn
    Wrenger, Carsten
    Honorio, Kathia M.
    Maltarollo, Vinicius G.
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2018, 36 (16): : 4378 - 4391
  • [29] Design, synthesis and biological evaluations of novel farnesoid X receptor (FXR) agonists
    Zhu, Yuanju
    Zhang, Jay
    Min, Feng
    Yang, Xinying
    Li, Li
    Zhang, Yan
    Hou, Xuben
    Fang, Hao
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2022, 76
  • [30] Immunolocalization of farnesoid X receptor (FXR) in mouse tissues using tissue microarray
    Higashiyama, Hiroyuki
    Kinoshita, Mine
    Asano, Satoshi
    ACTA HISTOCHEMICA, 2008, 110 (01) : 86 - 93
12345